← Open Payments lookup

KAREN PARKER: Open Payments

NPI 1982910824 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$516 in 22 payments from 12 companies in 2025. Trend: 2023 $628 · 2024 $455 · 2025 $516

Food & beverage: $516
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP3$147
PFIZER INC.4$92
Novo Nordisk Inc4$69
GlaxoSmithKline, LLC.3$56
ABBVIE INC.1$24
Neurelis, Inc.1$23
Axsome Therapeutics, Inc.1$20
Boehringer Ingelheim Pharmaceuticals, Inc.1$19
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$18
Lilly USA, LLC1$17

Products named: FARXIGA, PREVNAR 20, Rybelsus, TRELEGY ELLIPTA, AIRSUPRA, VRAYLAR, VALTOCO, AREXVY.

Industry payments across LA — which companies pay providers there.